Chymopapain approved.
D002917:Chymopapain / Q000009:adverse effects / Q000627:therapeutic use*; D010450:Endopeptidases / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007405:Intervertebral Disc Displacement / Q000188:drug therapy*; D008297:Male; D014481:United States; D014486:United States Food and Drug Administration
D010450:Endopeptidases; D002917:Chymopapain